Since its founding in 1997, Neoventa has been a driving force in the development of fetal monitoring solutions. Today, over 2,000 Stan devices are installed in 450 hospitals all over the world, we have educated more than 6,000 clinicians in fetal physiology and CTG interpretation and over 2.5 million deliveries have been monitored using Neoventa technology. Together with our customers and partners, we will continue our journey always striving for better results and a safe delivery for every mother and child.
